Servier completes the acquisition of Day One Biopharmaceuticals

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Servier-Day-One-Bio

More Like This

PR Newswire associated0

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

PR Newswire associated0

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

Business Wire logo

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

BeOne Medicines' biologics manufacturing facility and clinical R&D center in Hopewell, NJ.

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology

Business Wire logo

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

PR Newswire associated0

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio